Health in Burkina Faso 1,466 indicators covering health for Burkina Faso. IndicatorLatest Year10-yr change Rank Prevalence of anaemia in children aged 6-59 months 76.6% 2019 down 12.1% 3rd Mean hemoglobin level of children aged 6-59 months 98 2019 up 7.7% 192nd Estimated number of MDR/RR-TB incident cases 250 2024 down 19.4% 74th Neonatal mortality rate - Remains constant 23.75 2030 unchanged 25th Neonatal mortality rate - Current trends maintained 21.24 2030 down 8.9% 29th Neonatal mortality rate - High-income country average rate matched 2.8 2030 down 83.2% 1st Neonatal mortality rate - SDG target met 12 2030 down 43.4% 1st Under 5 mortality rate - Remains constant 74.89 2030 unchanged 11th Under 5 mortality rate - Current trends maintained 61.65 2030 down 15.0% 13th Under 5 mortality rate - High-income country average rate matched 5.09 2030 down 89.1% 1st Under 5 mortality rate - SDG target met 25 2030 down 59.3% 1st Mortality rate age 10-19 - Remains constant 9.2 2030 up 6.6% 41st Mortality rate age 10-19 - Current trends maintained 6.69 2030 down 17.8% 52nd Mortality rate age 10-19 - High-income country average rate matched 4.63 2030 down 29.5% 51st Neonatal deaths - Remains constant 18,318 2030 up 4.0% 26th Neonatal deaths - Current trends maintained 16,384 2030 down 5.2% 27th Neonatal deaths - SDG target met 9,256 2030 down 41.1% 35th Under-five deaths - Remains constant 56,779 2030 up 4.2% 22nd Under-five deaths - Current trends maintained 46,714 2030 down 11.4% 24th Under-five deaths - SDG target met 19,028 2030 down 57.3% 34th Deaths age 10 to 19 - Remains constant 5,450 2030 up 9.6% 42nd Deaths age 10 to 19 - Current trends maintained 4,310 2030 down 9.8% 45th Number of deaths attributed to non-communicable diseases, by type of 9,452 2019 up 56.3% 88th Hepatitis B surface antigen (HBsAg) prevalence 0.7% 2024 down 22.2% 43rd Mortality caused by road traffic injury 31 per 100,000 population 2019 up 5.4% 21st Mortality caused by road traffic injury, female 21.3 per 100,000 female population 2019 up 5.4% 9th Mortality caused by road traffic injury, male 40.8 per 100,000 male population 2019 up 5.2% 31st Share of one-year-olds who received the inactivated polio vaccine 91.0% 2024 up 102.2% 110th Deaths in armed conflicts by country, annual growth rate -82.28 % change on previous year 2026 up 17.7% 15th Deaths in armed conflicts by region, annual growth rate -82.28 % change on previous year 2026 up 17.7% 15th Proportion of health care facilities with limited water services 21.25 2025 up 48.4% 32nd Tuberculosis patients living with HIV receiving antiretroviral therapy 367 patients 2021 down 36.7% 56th HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2024 up 16.3% 1st Treatment success rate for patients treated for MDR-TB 69.0% 2022 up 19.0% 101st New leprosy case detection rate per 1 000 000 population 7.01 2024 down 41.3% 53rd Treatment success rate: HIV-positive TB cases 75 2023 up 5.6% 74th Prevalence of wasting, weight for height 9.3% 2021 down 10.6% 13th Estimated number of children (aged 0-17 years) who have lost one or 980,000 2024 up 16.7% 26th Weight-for-height <-2 SD 9.34 2021 down 10.1% 13th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 85.0% 2025 — 101st International Health Regulations core capacity scores, SPAR version 30 2025 — 139th Prevalence of underweight, weight for age 16.9% 2021 down 32.7% 23rd Leprosy registered prevalence rate per 1 000 000 population 7.47 2024 down 34.6% 57th Leprosy - Number of new leprosy cases among children 14 2024 up 133.3% 31st Leprosy - Number of cases registered for treatment 176 2024 down 11.6% 43rd New leprosy child case detection rate (less than 15 years of age) per 1.42 2024 up 90.9% 41st Children (0-14) living with HIV 8,400 2024 down 47.5% 24th Deaths in armed conflicts, annual growth rate 20.87 % change on previous year 2025 up 120.9% 18th Number of one-year-olds who have not received the inactivated polio vaccine 60,734 one-year-olds 2023 down 84.2% 48th Children living with HIV 8,400 0-14 2024 down 47.5% 24th Contraceptive prevalence, any method 34.0% 2022 up 109.6% 90th Children (ages 0-14) newly infected with HIV 800 2024 down 42.9% 26th Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Age-standardized prevalence of current tobacco use among persons aged 11.6% 2024 down 29.7% 112th Annual number of children newly infected with HIV 800 ages 0-14 2024 down 42.9% 26th Children newly infected with HIV 800.68 infections 2024 down 42.1% 26th Number of female leprosy new cases 8 2024 down 92.7% 65th Estimated number of malaria deaths 16,184 2024 down 33.0% 10th Estimated number of malaria cases 8.32 million 2024 up 2.4% 10th National smoking ban: NUMBER OF PLACES SMOKE-FREE 8 2022 unchanged 1st ← Previous Page 18 of 25 Next →